GO:0032673 regulation of interleukin-4 production: Immune Cytokine Control, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0032673 regulation of interleukin-4 production describes any biological process that modulates the frequency, rate, or extent of interleukin-4 (IL-4) production, including its biosynthesis and secretion.
• IL-4 is a type 2 cytokine produced mainly by activated CD4+ T helper 2 (Th2) cells, type 2 innate lymphoid cells (ILC2s), basophils, mast cells, and eosinophils.
• Regulation occurs at transcriptional, post-transcriptional, and spatial levels, with GATA3, NFAT, and STAT6 among the best-characterized control nodes.
• IL-4 production is not uniform across cells; probabilistic or stochastic regulation generates heterogeneous cytokine output in T cell populations.
• Dysregulated IL-4 production is linked to asthma, allergy, atopic dermatitis, and tumor immune microenvironment remodeling [1,7].
• CRISPR knockout, knock-in, point-mutation, and overexpression models enable causal dissection of genes that regulate IL-4 production [2,8].
Description
GO:0032673 regulation of interleukin-4 production is a Gene Ontology biological process term that captures any mechanism controlling the frequency, rate, or extent of IL-4 production. IL-4 is a pleiotropic type 2 cytokine that signals through the type I IL-4 receptor (IL-4Ralpha/gamma-c) and the type II receptor (IL-4Ralpha/IL-13Ralpha1), and it is central to Th2 differentiation, IgE class switching, alternative macrophage activation, and allergic inflammation. Because IL-4 output is tightly controlled, the regulatory processes annotated to GO:0032673 are essential for immune homeostasis and for preventing pathological type 2 inflammation. IL-4 is produced predominantly by activated CD4+ T cells, but also by ILC2s, basophils, mast cells, and eosinophils, and its production is restricted compared with other cytokines such as IL-2 or IFN-gamma. This restricted production reflects multilayered regulation, including lineage-determining transcription factors, chromatin remodeling, and spatial control of cytokine secretion [2,5]. Understanding GO:0032673 therefore requires integrating transcriptional, post-transcriptional, and cell-biological perspectives [2,8]. For researchers, GO:0032673 provides a standardized framework to annotate genes, pathways, and perturbations that alter IL-4 output. It is used in immunology, allergy, asthma, and immuno-oncology studies, and it supports comparative analysis of cytokine regulation across cell types and species [1,2,7]. The term is also a practical target for CRISPR-based functional genomics, where knockout or knock-in models can test whether a candidate gene causally regulates IL-4 production [2,8].
regulation of interleukin-4 production At A Glance
| GO ID | GO:0032673 |
|---|---|
| GO term | regulation of interleukin-4 production |
| Ontology | biological_process |
| Definition | Any process that modulates the frequency, rate, or extent of interleukin-4 production. |
| Synonyms | regulation of IL-4 production; regulation of interleukin-4 biosynthetic process; regulation of interleukin-4 secretion |
| Major function | Controls the amount and timing of IL-4 cytokine available for type 2 immune responses [1,2]. |
| Primary cell types | Activated CD4+ Th2 cells, ILC2s, basophils, mast cells, eosinophils [2,4]. |
| Key regulators | GATA3, NFAT, STAT6, TCR signaling, and cytokine receptor feedback. |
| Disease relevance | Asthma, allergy, atopic dermatitis, and tumor immune microenvironment [1,7]. |
What Is GO:0032673?
In plain terms, GO:0032673 regulation of interleukin-4 production refers to any process that changes how much IL-4 a cell makes or releases, including changes in the frequency, rate, or extent of IL-4 biosynthesis and secretion. It is a biological process term, not a molecular function or cellular component term, and it encompasses both positive and negative regulation. The term includes regulation of IL-4 biosynthetic process and regulation of IL-4 secretion, reflecting that production can be controlled at synthesis and release steps [1,2].
Why Is regulation of interleukin-4 production Important in Cell Biology?
GO:0032673 is important because IL-4 is a master type 2 cytokine whose production level determines the balance between protective immunity and allergic pathology [1,2]. Even modest changes in IL-4 output can shift Th2 differentiation, IgE production, and macrophage polarization, making its regulation a central node in immune decision-making. Because IL-4 production is restricted and heterogeneous across cells, the regulatory processes annotated to GO:0032673 are also a model for understanding probabilistic gene expression in the immune system.
• IL-4 production drives Th2 cell differentiation and type 2 immune responses.
• IL-4 regulates IgE class switching and allergic inflammation.
• IL-4 production is restricted to specific activated cell types, making its regulation a model of cell-type-specific cytokine control.
• Spatial regulation of IL-4 signaling influences in vivo immune outcomes.
• Dysregulated IL-4 production contributes to asthma and atopic disease.
• IL-4 production is probabilistically regulated, generating heterogeneous responses within clonal populations.
• IL-4 and IL-13 production can be differentially regulated by cytokines such as interferon alpha.
• IL-4 receptor complexes determine how produced IL-4 is sensed and fed back into regulation.
• GO:0032673 supports annotation and enrichment analysis in immunology and allergy genomics.
• CRISPR models of IL-4 regulatory genes enable causal testing of disease-associated variants [2,8].
What Happens During regulation of interleukin-4 production?
Signal integration and T cell activation
In simple terms: First, the cell receives external signals that tell it whether to start making IL-4.
Regulation of IL-4 production begins with antigen recognition and co-stimulation through the T cell receptor and CD28, which activate transcription factors and chromatin changes needed for cytokine gene expression. Cytokine signals from the microenvironment, including IL-4 itself and interferon alpha, further shape whether a cell becomes a high IL-4 producer [1,3]. This integration step determines the frequency of cells that will produce IL-4, a key parameter in GO:0032673.
Transcriptional control of the IL-4 locus
In simple terms: Next, transcription factors bind DNA and switch on the IL-4 gene.
The IL-4 gene is controlled by enhancer and promoter elements bound by transcription factors such as GATA3, NFAT, and STAT6, which are central to Th2 differentiation and IL-4 production. GATA3 is considered a master regulator that promotes and maintains IL-4 expression, while other factors can repress it. This transcriptional layer is the most direct target of GO:0032673 annotations.
Post-transcriptional and secretory regulation
In simple terms: After the gene is switched on, the cell still controls how much IL-4 protein is made and released.
IL-4 production is also regulated after transcription, including mRNA stability, translation, and secretory trafficking, and the term explicitly includes regulation of IL-4 secretion [1,2]. Spatial regulation of IL-4 signaling in vivo indicates that where and when IL-4 is released affects its function, adding a spatial dimension to GO:0032673. These layers allow cells to fine-tune IL-4 output without changing transcription.
Probabilistic and heterogeneous production
In simple terms: Not every cell makes IL-4 at the same time, even if they are genetically identical.
IL-4 production is probabilistically regulated, meaning that individual cells within a population can stochastically switch between producing and non-producing states. This heterogeneity is a regulated feature rather than noise, and it influences population-level cytokine responses. GO:0032673 therefore includes processes that set the probability and frequency of IL-4 production, not only its average amount.
Feedback through IL-4 receptor complexes
In simple terms: Once IL-4 is released, it can signal back to the cell and adjust future production.
IL-4 signals through type I and type II receptor complexes, activating STAT6 and other pathways that reinforce or modulate Th2 programs. This feedback can sustain IL-4 production in differentiated Th2 cells or alter responsiveness in other cell types [1,2]. Receptor-mediated feedback is thus part of the broader regulatory network surrounding GO:0032673.
Key Genes Involved in GO:0032673 regulation of interleukin-4 production
The following genes and proteins are established participants in the regulation of IL-4 production, based on published immunology literature [1,2,3,4,5,7,8].
| Gene | Major Role | Research Relevance |
|---|---|---|
| IL4 | Encodes the IL-4 cytokine whose production is regulated | Direct target of GO:0032673; knockout and reporter models quantify production [1,2] |
| GATA3 | Master transcription factor promoting Th2 differentiation and IL-4 expression | Central regulator; knockout reduces IL-4 production |
| STAT6 | Signal transducer downstream of IL-4 receptor; reinforces Th2 programs | Feedback regulator of IL-4 production [1,2] |
| NFATC1 | Calcineurin-responsive transcription factor activating cytokine genes | TCR-dependent regulator of IL-4 transcription |
| IL4R | IL-4 receptor alpha chain mediating IL-4 sensing | Determines feedback and responsiveness |
| IL13RA1 | Type II receptor component for IL-4 and IL-13 signaling | Modulates IL-4 sensing in non-hematopoietic cells |
| IFNAR1 | Interferon alpha receptor subunit | Interferon alpha differentially regulates IL-4 and IL-13 production |
| IFNAR2 | Interferon alpha receptor subunit | Contributes to interferon-mediated suppression of type 2 cytokines |
| TBX21 | T-bet transcription factor promoting Th1 and suppressing Th2 programs | Negative regulator of IL-4 production |
| RORC | Transcription factor for Th17 programs | Context-dependent cross-regulation of cytokine production |
| FOXP3 | Regulatory T cell transcription factor | Suppresses effector cytokine production including IL-4 |
| MAF | Transcription factor supporting IL-4 expression in Th2 cells | Cooperative regulator with GATA3 |
| IRF4 | Interferon regulatory factor supporting Th2 responses | Modulates IL-4 production capacity |
| BATF | Transcription factor cooperating in Th2 cytokine regulation | Context-dependent regulator |
| NFKB1 | NF-kappa-B subunit mediating inflammatory transcription | Contributes to cytokine gene activation |
| PRKCQ | Protein kinase C theta in TCR signaling | Upstream signaling regulator of IL-4 production |
| ITK | Tec kinase in TCR signaling | Modulates calcium-NFAT pathway for IL-4 |
| CD28 | Co-stimulatory receptor | Required for optimal IL-4 production |
How Is regulation of interleukin-4 production Regulated?
Regulation of IL-4 production is itself regulated at multiple levels. TCR and co-stimulatory signaling through CD28 and ITK/PRKCQ activates calcium-calcineurin-NFAT and NF-kappa-B pathways that cooperate with GATA3 to induce IL-4 transcription. Cytokine feedback through IL-4 receptor complexes and STAT6 sustains Th2 programs, while interferon alpha can differentially regulate IL-4 and IL-13 production [1,3]. Negative regulators such as TBX21 and FOXP3 suppress IL-4 production, and probabilistic switching controls the fraction of producing cells [2,8]. Spatial and temporal control of IL-4 release further tunes signaling outcomes in vivo.
regulation of interleukin-4 production and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| IL4 | Asthma and allergic inflammation | IL-4 reporter knock-in and knockout T cell models |
| GATA3 | Th2-driven allergy and asthma | Conditional knockout in CD4+ T cells |
| STAT6 | Type 2 immune pathology | Point-mutation of STAT6 activation site [1,2] |
| IL4R | Allergic and atopic disease | Knockout and knock-in receptor variants |
| IFNAR1 | Interferon-modulated type 2 inflammation | Knockout with interferon alpha treatment |
Asthma and allergic inflammation
IL-4 is a central driver of allergic airway inflammation, and alternatively spliced IL-4 protein variants have been detected in asthma, linking regulation of IL-4 production to disease severity. Type 2 cytokine production by Th2 cells and ILC2s underlies asthma pathophysiology, making GO:0032673 a key process for therapeutic targeting [1,2].
Atopic dermatitis and IgE-mediated allergy
IL-4 promotes IgE class switching and Th2 polarization, and dysregulated IL-4 production contributes to atopic dermatitis and other allergic disorders [1,2]. Regulation of IL-4 production therefore influences both initiation and persistence of allergic inflammation.
Tumor immune microenvironment
IL-4 and IL-13 shape macrophage polarization and can promote tumor-associated type 2 inflammation, and receptor complex signaling determines these outcomes. Regulation of IL-4 production is thus relevant to immuno-oncology studies of type 2 immunity [1,2].
Infectious and inflammatory disease contexts
Interferon alpha differentially regulates IL-4 and IL-13 production, indicating that viral or interferon-rich environments can reshape type 2 cytokine output. This has implications for infection-associated immune deviation and inflammatory disease.
From regulation of interleukin-4 production-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for IL-4 production? | CRISPR knockout in primary CD4+ T cells or Jurkat reporter lines |
| Does a disease variant alter IL-4 output? | Point-mutation knock-in at the endogenous locus [2,8] |
| Can a regulatory element drive IL-4 expression? | Knock-in of reporter or degron tags at the IL-4 locus |
| Does overexpression of a transcription factor increase IL-4? | Doxycycline-inducible overexpression in T cell lines |
| How heterogeneous is IL-4 production? | Single-cell reporter knock-in and flow cytometry |
| Does receptor feedback control IL-4 production? | IL4R or STAT6 knockout with cytokine stimulation [1,2] |
How to Study the regulation of interleukin-4 production Process
| Method | What It Measures | Typical Application |
|---|---|---|
| ELISPOT | Frequency of IL-4-secreting cells | Probabilistic regulation studies |
| Intracellular cytokine staining | Fraction of cells producing IL-4 | Th2 differentiation assays |
| ELISA/Luminex | IL-4 protein concentration | Cytokine production quantification [1,3] |
| RNA-seq | IL-4 and regulatory gene expression | Transcriptional profiling |
| ATAC-seq/ChIP-seq | Chromatin accessibility and factor binding | IL-4 locus regulation |
| CRISPR screening | Genes required for IL-4 production | Functional genomics [2,8] |
| Reporter mouse imaging | Spatial IL-4 production in vivo | Tissue-level regulation |
| Flow cytometry | Surface and intracellular markers | Cell-type-specific production |
Single-cell cytokine assays
Flow cytometry, ELISPOT, and single-cell reporter systems quantify the frequency of IL-4-producing cells, directly measuring the probabilistic regulation described for GO:0032673. These methods are essential because population averages can mask heterogeneity.
Transcriptional and epigenomic profiling
RNA-seq, ATAC-seq, and ChIP-seq for GATA3, NFAT, and STAT6 identify regulatory elements and transcription factor binding at the IL-4 locus. These approaches map the transcriptional layer of GO:0032673.
Cytokine protein quantification
ELISA, Luminex, and intracellular cytokine staining measure IL-4 protein levels and secretion, covering both biosynthetic and secretory regulation [1,2]. Differential regulation of IL-4 versus IL-13 can be resolved with multiplex assays.
Spatial and in vivo imaging
Reporter mice and imaging approaches reveal where and when IL-4 is produced and sensed in tissues, addressing spatial regulation of IL-4 signaling. These models connect GO:0032673 to in vivo physiology.
How CRISPR Can Be Used to Study GO:0032673 regulation of interleukin-4 production
Knockout
CRISPR knockout of candidate regulators such as GATA3, STAT6, or IL4R in T cell lines or primary cells tests whether a gene is required for IL-4 production. Knockout of the IL4 gene itself provides a negative control for production assays.
Point Mutation
Point-mutation knock-in can model disease-associated variants in regulatory elements or transcription factor binding sites and measure their effect on IL-4 output [2,8]. This approach links genotype to cytokine phenotype.
Knock-in
Knock-in of fluorescent reporters, epitope tags, or degron tags at the IL-4 locus enables real-time tracking of production and protein stability [2,8]. Tagged knock-in also supports chromatin and interaction studies at the endogenous locus.
Overexpression
Doxycycline-inducible overexpression of transcription factors or signaling molecules tests sufficiency for increased IL-4 production. Overexpression models complement knockout by establishing whether a gene is sufficient to drive the process.
How EDITGENE Supports regulation of interleukin-4 production Research
Researchers studying regulation of interleukin-4 production-related genes often need to determine whether a candidate gene is causally involved in controlling IL-4 output, rather than merely correlated with it. CRISPR-based perturbation provides that causal link by introducing defined edits at endogenous loci and measuring the resulting cytokine phenotype [2,8].
Contact EDITGENE today to design your custom CRISPR model for regulation of interleukin-4 production research.
Frequently Asked Questions About regulation of interleukin-4 production
What is GO:0032673 regulation of interleukin-4 production?
It is a Gene Ontology biological process term describing any process that modulates the frequency, rate, or extent of IL-4 production, including biosynthesis and secretion [1,2].
What genes are involved in regulation of interleukin-4 production?
Key genes include IL4, GATA3, STAT6, NFATC1, IL4R, IL13RA1, TBX21, FOXP3, MAF, IRF4, and BATF, among others [1,2].
Which cells produce interleukin-4?
IL-4 is produced mainly by activated CD4+ Th2 cells, ILC2s, basophils, mast cells, and eosinophils [2,4].
How is IL-4 production regulated?
It is regulated at transcriptional, post-transcriptional, secretory, and spatial levels, with probabilistic switching in cell populations [2,5,8].
Why is regulation of IL-4 production important in asthma?
IL-4 drives Th2 inflammation and IgE responses, and alternatively spliced IL-4 variants are detected in asthma [1,7].
Does interferon alpha affect IL-4 production?
Yes, interferon alpha differentially regulates IL-4 and IL-13 production.
Is IL-4 production stochastic?
Yes, IL-4 production is probabilistically regulated, producing heterogeneous responses within clonal populations.
What is the difference between IL-4 production and IL-4 signaling?
Production refers to making and releasing IL-4, while signaling refers to how IL-4 is sensed through receptor complexes [1,2].
How can CRISPR help study regulation of IL-4 production?
CRISPR knockout, knock-in, point mutation, and overexpression models test causal roles of candidate genes in IL-4 output [2,8].
What methods measure IL-4 production?
ELISPOT, intracellular cytokine staining, ELISA, Luminex, RNA-seq, and reporter imaging are commonly used [1,2,5,8].
Conclusion
GO:0032673 regulation of interleukin-4 production provides a precise ontology framework for the multilayered control of IL-4 output, spanning transcription, post-transcriptional regulation, secretion, and probabilistic cell-to-cell heterogeneity [1,2,8]. Its importance extends from basic Th2 immunology to asthma, allergy, and tumor immunology, where IL-4 levels shape disease outcomes [1,7]. CRISPR-based models now allow researchers to move from correlation to causation when studying genes annotated to this process [2,8]. By combining knockout, point-mutation, knock-in, overexpression, and screening approaches with cytokine and single-cell readouts, the field can systematically map the regulatory network controlling IL-4 production [2,8].
References
- 1. Junttila IS. 2018. Tuning the Cytokine Responses: An Update on Interleukin (IL)-4 and IL-13 Receptor Complexes.. Front Immunol 9:888 PMID: 29930549
- 2. Zhu J. 2015. T helper 2 (Th2) cell differentiation, type 2 innate lymphoid cell (ILC2) development and regulation of interleukin-4 (IL-4) and IL-13 production.. Cytokine 75(1):14-24 PMID: 26044597
- 3. Kaser A et al.. 1998. Differential regulation of interleukin 4 and interleukin 13 production by interferon alpha.. Cytokine 10(2):75-81 PMID: 9512896
- 4. Lewis DB et al.. 1988. Restricted production of interleukin 4 by activated human T cells.. Proc Natl Acad Sci U S A 85(24):9743-7 PMID: 3144002
- 5. Redpath SA et al.. 2015. Spatial regulation of IL-4 signalling in vivo.. Cytokine 75(1):51-6 PMID: 25819429
- 7. Luzina IG et al.. 2012. Natural production and functional effects of alternatively spliced interleukin-4 protein in asthma.. Cytokine 58(1):20-6 PMID: 22249152
- 8. Guo L et al.. 2005. Probabilistic regulation of IL-4 production.. J Clin Immunol 25(6):573-81 PMID: 16380820
